Contact Your Member of Congress to Oppose "Most Favored Nation" Model
On November 20, CMS finalized a mandatory, seven-year model to test paying “most favored nation” (MFN) prices for the 50 highest-spend Medicare Part B drugs to begin on January 1, 2021. These drugs are among the most innovative and effective treatments for complex, debilitating and potentially life-threatening conditions including cancers, autoimmune disorders, and rare diseases. If implemented, the MFN Model will drive a devastating wedge between physicians and patients, destroy the economic viability of community providers, and force patients to choose among untenable care options, such as accepting alternative, inferior treatment, finding a new provider, or forgoing treatment altogether. Take action urging Congress to stand up for patients and providers by opposing the MFN Model.
